Embedded Files
The global subcutaneous drug delivery devices market is projected to reach a valuation of USD 51.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2025 to 2030, according to a recent report by Grand View Research, Inc. This robust market expansion is primarily driven by the rising prevalence of chronic health conditions, coupled with the increasing necessity for regular administration of medications aimed at alleviating disease-related symptoms. These factors have significantly fueled the demand for in-home drug delivery solutions, particularly subcutaneous delivery devices.
According to the Centers for Disease Control and Prevention (CDC), in 2018, approximately 54.4 million adults in the United States — equating to 22.7% of the adult population — were diagnosed with chronic conditions such as arthritis, fibromyalgia, gout, or lupus. The CDC further estimates that by the year 2040, this figure will increase to 78.0 million adults, representing 26.0% of the population, who are expected to be diagnosed with arthritis alone.
Additionally, the market is witnessing a surge in demand due to the increasing approval and utilization of biologic medications, particularly for the treatment of life-threatening diseases that necessitate large dosage volumes or prolonged delivery periods. These biologics often require subcutaneous administration for effective delivery. A study published by Informa U.K. in February 2019 revealed that the number of medicines in the clinical trial pipeline designated for parenteral administration rose from 53.0% in 2018 to 55.0% in 2019. In contrast, the development of oral formulations experienced a decline, falling from 33.0% in 2018 to 31.0% in 2019. This shift further emphasizes the growing preference for injectable solutions, including subcutaneous delivery methods.
Curious about the Subcutaneous Drug Delivery Devices Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends.
Subcutaneous Drug Delivery Devices Market Report Highlights
1. North America emerged as the leading regional market in terms of revenue share in 2024. This dominance is attributed to a combination of factors, including the high prevalence of chronic illnesses within the aging population and greater disposable income, which facilitates the adoption of advanced medical technologies.
2. Based on product type, the injection pen segment is anticipated to witness the highest CAGR during the forecast period. This growth is largely due to the convenience associated with multi-dose medication delivery and the cost-effectiveness of these devices, making them a preferred option among patients.
3. In terms of distribution channels, retail pharmacies held the largest market share. The dominance of this segment is supported by the presence of major pharmacy chains that offer attractive promotional schemes and discounts on innovative drug delivery systems, thus enhancing accessibility and adoption among consumers.
4. Leading market players are increasingly focusing on strategies such as strategic partnerships, collaborations, and continuous product innovations to effectively address the growing global demand for subcutaneous drug delivery solutions. These efforts are aimed at expanding market presence, improving patient outcomes, and staying competitive in the evolving healthcare landscape.
Subcutaneous Drug Delivery Devices Market Segmentation
Grand View Research has segmented the global subcutaneous drug delivery device market based on product, distribution channel, and region:
Subcutaneous Drug Delivery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
• Prefilled syringes
• Pen injectors
• Auto injectors
• Wearable injectors
• Needle-free Injectors
Subcutaneous Drug Delivery Devices Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Subcutaneous Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o Australia
o South Korea
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
List Of Key Players in the Subcutaneous Drug Delivery Devices Market
• Gerresheimer AG
• Medtronic Plc
• Ypsomed AG
• Elcam Medical Group
• Novo Nordisk
• Insulet Corporation
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• PharmaJet
• Unilife Corporation
• Inolife Sciences
Order a free sample PDF of the Subcutaneous Drug Delivery Devices Market Intelligence Study, published by Grand View Research.
Page updated
Google Sites
Report abuse